Man Group
IOVA icon

Man Group’s Iovance Biotherapeutics IOVA Stock Holding History

Man Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
252,959
+179,877
+246% +$683K ﹤0.01% 1840
2026
Q1 		$257K Buy
73,082
+18,561
+34% +$59.4K ﹤0.01% 2241
2025
Q4 		$149K Buy
54,521
+3,118
+6% +$7.21K ﹤0.01% 2162
2025
Q3 		$112K Buy
+51,403
New +$121K ﹤0.01% 2150
2025
Q2 		– Sell
-37,758
Closed -$126K – 2277
2025
Q1 		$126K Sell
37,758
-2,377,238
-98% -$12.3M ﹤0.01% 2096
2024
Q4 		$17.9M Buy
+2,414,996
New +$22.4M 0.05% 471
2024
Q2 		– Sell
-80,583
Closed -$1.19M – 2135
2024
Q1 		$1.19M Buy
80,583
+68,964
+594% +$803K ﹤0.01% 1477
2023
Q4 		$94.5K Buy
+11,619
New +$60.8K ﹤0.01% 1988
2023
Q3 		– Sell
-91,301
Closed -$596K – 1620
2023
Q2 		$643K Buy
+91,301
New +$653K ﹤0.01% 1512
2023
Q1 		– Sell
-49,104
Closed -$339K – 1355
2022
Q4 		$314K Buy
49,104
+31,159
+174% +$243K ﹤0.01% 1638
2022
Q3 		$172K Buy
+17,945
New +$207K ﹤0.01% 1792
2022
Q2 		– Hold
0
– – – 1819
2020
Q3 		– Sell
-235,704
Closed -$6.47M – 1827
2020
Q2 		$6.47M Buy
235,704
+217,854
+1,220% +$7.16M 0.03% 553
2020
Q1 		$534K Sell
17,850
-14,068
-44% -$373K ﹤0.01% 1268
2019
Q4 		$883K Sell
31,918
-50,365
-61% -$1.15M ﹤0.01% 1513
2019
Q3 		$1.5M Buy
+82,283
New +$1.82M 0.01% 1335

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Man Group's IOVA Position: Q2 2026 in Review

Man Group increased its Iovance Biotherapeutics (IOVA) stake by 246% in Q2 2026, buying an estimated $683K and bringing the position to 252,959 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1840.

Man Group first reported a position in IOVA in Q3 2019 and has held it in 15 quarters since. The position peaked at $17.9M in Q4 2024. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Man Group held 252,959 shares of Iovance Biotherapeutics worth $1.05M as of Q2 2026.
  • Man Group bought 179,877 Iovance Biotherapeutics shares in Q2 2026, an estimated $683K.
  • Iovance Biotherapeutics made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1840 holding.
  • Man Group first reported a position in Iovance Biotherapeutics in Q3 2019 and has held it in 15 quarters since.
  • Man Group's Iovance Biotherapeutics position peaked at $17.9M in Q4 2024.
  • 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.